On November 18, Glorious Exchange announced that ruisen life ser (01922.HK) received a letter from the Stock Exchange on November 11, 2024, which outlined the guidelines for the resumption of trading of the company's shares on the Stock Exchange. According to the resumption guidelines, the company must:

(a) publish all outstanding financial results in accordance with the listing rules and address any audit revision comments; (b) conduct an appropriate independent forensic investigation into the allegations, report the findings of the investigation, assess the impact on the company's business operations and financial condition, and take appropriate remedial measures; (c) demonstrate that the integrity, capability, and/or character of the group's management and any individuals who have significant influence over the company's management and operations do not raise reasonable regulatory concerns, as this may pose risks to investors and undermine market confidence; (d) conduct an independent internal control review and demonstrate that the company has established adequate internal controls and procedures to fulfill its responsibilities under the listing rules; (e) demonstrate compliance with Article 13.24 of the listing rules; (f) resume compliance with Article 13.92 of the listing rules; and (g) disclose all material information to the market for the company's shareholders and other investors to assess the company's condition. Trading will continue to be suspended.